![[ICO]](/icons/blank.gif){kind=icon}
![[PARENTDIR]](/icons/back.gif){kind=icon}
![[ ]](/icons/layout.gif){kind=icon}
| Name | Last modified | Size | Description |
|---|---|---|---|---|
| Parent Directory | - | ||
| 1_2022_wAMD_Brolucizumab_Review-efficacy-safety-NMA_Adv-Ther_Finger.pdf | 2022-10-28 15:18 | 1.8M | |
| 2_Bulirsch 2021_SHIFT STUDY.pdf | 2022-10-28 15:18 | 1.9M | |
| 3_2022_wAMD_Brolucizumab_RW Short term naive_JJO_Tanaka.pdf | 2022-10-28 15:18 | 806K | |
| 4_2022_wAMD_Brolucizumab_RW naive Type 1_Ophthalmic Res_Toto.pdf | 2022-10-28 15:18 | 2.6M | |
| 5_Fukuda_PCV_2021.pdf | 2022-10-28 15:18 | 1.7M | |
| 6_Airaldi_type 1 polipoidal.pdf | 2022-10-28 15:18 | 1.1M | |
| 7_2022_wAMD_Brolucizumab_RW 1Y exp PCV_Scirep_Ito.pdf | 2022-10-28 15:18 | 1.2M | |
| 8_Rispoli_biomedicines-09-00668_2021 (003).pdf | 2022-10-28 15:18 | 1.0M | |
| 9_Mukai PED.pdf | 2022-10-28 15:18 | 1.0M | |
| 10_2022_wAMD_Brolucizumab_RW Type 3 RAP_Medicina_Gigon.pdf | 2022-10-28 15:18 | 2.5M | |
| prof-lupidi-review-brolucizumab.pdf | 2022-11-14 08:08 | 8.8M | |